RecruitingNCT07621055

VOLta Medical AI-software in REal-World During AF Ablation

Real-World Experience of Volta Medical AI-software During AF Ablation Using Next-generation Mapping and Ablation Technologies


Sponsor

Volta Medical

Enrollment

150 participants

Start Date

Jun 16, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This PMCF study "VOLTAIRE-AF" will allow to observe acute and long-term safety and performance outcomes of the last generation of Volta Medical AI software (Volta AF-Xplorer II) during AF ablation using next-generation mapping and ablation technologies over a 24-month follow-up and in "real life"clinical practice, without any imposed clinical workflow.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patient aged 18 years or older.
  • Patient candidate for catheter ablation to treat paroxysmal or persistent atrial fibrillation, atrial tachycardia, de novo or after one or several previous ablation procedures, and for which the investigator considers using Volta AF-Xplorer II.
  • Patient able and willing to provide written informed consent to participate in the study.
  • Only for France: Patient affiliated to the French social security system.

Exclusion Criteria6

  • Contraindication to AF/AT catheter ablation using RF and/or PFA.
  • Patient who is or could potentially be pregnant.
  • Person deprived of liberty or under guardianship.
  • Person unable to undergo a medical monitoring for geographical, social or psychological reasons.
  • Patient's refusal to participate in the study.
  • Enrollment in a premarket clinical study evaluating device, drug or biologic product.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECardiac mapping

All patients enrolled are treated for their atrial fibrillation/tachycardia via a catheter ablation procedure using the last generation of Volta Medical AI software (Volta AF-Xplorer II, used in accordance with its approved indication as per of its IFU) during the mapping phase to identify areas of interest specific to the patient. The ablation approach is free and chosen by the operator according to his standard practice. The two main phases of the ablation procedure are: * 3D mapping of the atria and location of areas of interest; * Catheter ablation at the operator's discretion.


Locations(3)

Hôpital Saint-Joseph Marseille

Marseille, France

Centre Cardiologique du Nord

Saint-Denis, France

Clinique Rhéna

Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07621055


Related Trials